FindTrial
Sign In

Exploring the effect of antinuclear antibodies on pregnancy and their role in the occurrence of miscarriage

Exploring the effect of antinuclear antibodies on pregnancy and their role in the occurrence of miscarriage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070402
Enrollment
Unknown
Registered
2023-04-11
Start date
2023-04-12
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abortion

Interventions

case series:None

Sponsors

Yuyao People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Women of childbearing aged between 18 and 45 years. 2. Patients with blood hcg were examined in Yuyao People's Hospital within 12 weeks of pregnancy and had the intention to continue pregnancy this time.

Exclusion criteria

Exclusion criteria: Pregnant women with serious medical and surgical conditions (meet one of the following criteria) : 1. Severe hypertension (systolic blood pressure greater than 180 mmHg or diastolic blood pressure greater than 110 mmHg); 2. Severe diabetes mellitus (fasting blood glucose level greater than 11.1mmol/L); 3. History of malignant tumor; 4. Patients with cardiovascular and cerebrovascular diseases (Grade III-IV cardiac function).

Design outcomes

Primary

MeasureTime frame
Antinuclear antibodies;—

Secondary

MeasureTime frame
Immunoinflammatory factor;—

Countries

China

Contacts

Public ContactTu Lili

Yuyao People's Hospital

3936544409@qq.com+86 13655849516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026